GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (NSE:ORTINGLOBE) » Definitions » Revenue

Ortin Global (NSE:ORTINGLOBE) Revenue : ₹4.42 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ortin Global Revenue?

Ortin Global's revenue for the three months ended in Dec. 2024 was ₹0.34 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₹4.42 Mil. Ortin Global's Revenue per Share for the three months ended in Dec. 2024 was ₹0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.55.

Warning Sign:

Ortin Global Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Ortin Global was -87.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -36.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -60.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was -25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Ortin Global's highest 3-Year average Revenue per Share Growth Rate was 60.40% per year. The lowest was -68.20% per year. And the median was -18.80% per year.


Ortin Global Revenue Historical Data

The historical data trend for Ortin Global's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Global Revenue Chart

Ortin Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,973.91 81.67 82.31 60.20 21.12

Ortin Global Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 1.45 2.09 0.55 0.34

Competitive Comparison of Ortin Global's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ortin Global's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ortin Global's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ortin Global's Revenue distribution charts can be found below:

* The bar in red indicates where Ortin Global's Revenue falls into.


;
;

Ortin Global Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortin Global  (NSE:ORTINGLOBE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Ortin Global Revenue Related Terms

Thank you for viewing the detailed overview of Ortin Global's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Global Business Description

Traded in Other Exchanges
Address
Road No.12, Mayfair Gardens, 8-2-682/3/A & 3B, Flat No. 201, 2nd Floor, Banjara Hills, Khairatabad, Hyderabad, TG, IND, 500034
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. The company has two operating segments, including Manufacture and Trading. The company generates the majority of its revenue from the Trading division, which involves trading of Pharmaceuticals and medical Formulations.

Ortin Global Headlines

No Headlines